BookPDF Available

The Heart and Circulation - An Integrative Model

Authors:

Abstract and Figures

This extensively revised second edition traces the development of the basic concepts in cardiovascular physiology in light of the accumulated experimental and clinical evidence. It considers the early embryonic circulation, where blood circulation suggests the existence of a motive force, tightly coupled to the metabolic demands of the tissues. It proposes that rather than being an organ of propulsion, the heart, serves as an organ of control, generating pressure by rhythmically impeding blood flow. New and expanded chapters cover the arterial pulse, circulation in the upright posture, microcirculation and functional heart morphology. Heart and Circulation offers a new perspective for deeper understanding of the human cardiovascular system. It is therefore a thought-provoking resource for cardiologists, cardiac surgeons and trainees interested in models of human circulation.
No caption available
… 
No caption available
… 
Content may be subject to copyright.
1
TITLE LIST
FULL TITLE: Novel patterns of left ventricular mechanical activity during experimental cardiac arrest
in pigs
SHORT TITLE: Ventricular mechanical activity in cardiac arrest
AUTHORS: Roman Skulec, MD, PhD1,2,3; David Astapenko, MD1; Renata Cerna Parizkova, MD, PhD1;
Prof. Branko Furst, MD, FFARCSI4; Marcela Bilska, MD2; Tomas Parizek, MD2; Tomas Hovanec5;
Nikola Pinterova6; Jiri Knor, MD, PhD3,7; Jaroslava Dudakova3; Anatolij Truhlar, MD, PhD1,8; Vera
Radochova, DVM9; Prof. Zdenek Zadak, MD, PhD10,11 and Prof. Vladimir Cerny, MD, PhD,
FCCM1,2,10,12
AFFILIATIONS:
1Department of Anesthesiology and Intensive Care, Charles University in Prague, Faculty of Medicine in
Hradec Kralove, University Hospital Hradec Kralove, Hradec Kralove Czech Republic
2Department of Anesthesiology, Perioperative Medicine and Intensive Care, J.E. Purkinje University,
Masaryk Hospital Usti nad Labem, Usti nad Labem, Czech Republic
3Emergency Medical Service of the Central Bohemian Region, Kladno, Czech Republic
4Department of Anesthesiology, Albany Medical College, NY, United States of America
5Faculty of Medicine in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic
6Faculty of Science, Charles University in Prague, Prague, Czech Republic
73rd Medical Faculty, Charles University in Prague, Prague, Czech republic
8Hradec Kralove Region Emergency Medical Services, Hradec Kralove, Czech Republic
9Faculty of Military Health Sciences, University of Defence, Brno, Czech Republic
10Department of Research and Development, Charles University in Prague, Faculty of Medicine in
Hradec Kralove, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
113rd Department of Internal Medicine Metabolic Care and Gerontology, Charles University in Prague,
Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Hradec Kralove, Czech
Republic
12Department of Anesthesia, Pain Management and Perioperative Medicine, Dalhousie University,
Halifax, Nova Scotia, Canada
FIRST AND CORRESPONDING AUTHOR: Roman Skulec
Corresponding address: Roman Skulec, Department of Anesthesiology, Perioperative Medicine
and Intensive Care, Masaryk Hospital Usti nad Labem, Socialni pece 3316 /12A, Usti nad Labem 401 13,
Czech Republic
Email: skulec@email.cz Phone: 00420 777 577 497 Fax: 00420 477 115 020
2
SUMMARY
We conducted an experimental study to evaluate the presence of coordinated left ventricular mechanical
myocardial activity (LVMA) in two types of experimentally induced cardiac arrest: ventricular fibrillation
(VF) and pulseless electrical activity (PEA). Twenty anesthetized domestic pigs were randomized 1:1
either to induction of VF or PEA. They were left in nonresuscitated cardiac arrest until the cessation of
LVMA and microcirculation. Surface ECG, presence of LVMA by transthoracic echocardiography and
sublingual microcirculation were recorded. One minute after induction of cardiac arrest, LVMA was
identified in all experimental animals. In the PEA group, rate of LVMA was of 106±12/min. In the VF
group, we identified two patterns of LVMA. Six animals exhibited contractions of high frequency (VFhigh
group), four of low frequency (VFlow group) (334±12 vs. 125±32/min., p<0.001). A time from cardiac
arrest induction to asystole (19.2±7.2 vs. 7.3±2.2 vs. 8.3±5.5 min, p=0,003), cessation of LVMA
(11.3±5.6 vs. 4.4±0.4 vs. 7.4±2.9 min, p=0.027) and cessation of microcirculation (25.3±12.6 vs.
13.4±2.4 vs. 23.2±8.7 min, p=0.050) was significantly longer in VFlow group than in VFhigh and PEA
group, respectively. Thus, LVMA is present in both VF and PEA type of induced cardiac arrest and
moreover, VF may exhibit various patterns of LVMA.
Key words: experimental cardiac arrest, left ventricular mechanical activity
3
Introduction
Implementation of point-of-care echocardiography in clinical and experimental resuscitation medicine has
brought new knowledge about the cardiac arrest (Soar et al. 2015). It has been documented that the
clinical syndrome of cardiac arrest is not always accompanied by the presence of mechanical cardiac
standstill (Bocka et al. 1988, Breitkreutz et al. 2010). Conversely, in most cases of pulseless electrical
activity (PEA) and in some patients presenting with asystole, a preserved coordinated left ventricular
mechanical myocardial activity (LVMA) can be observed (Breitkreutz et al. 2010, Cohn et al. 2013). It
has been shown that the presence or absence of LVMA exhibits a strong predictive prognostic value for
achieving return of spontaneous circulation (ROSC) (Blyth et al. 2012, Blaivas et al. 2001). The absence
of LVMA during cardiopulmonary resuscitation (CPR) of patients with non-shockable rhythm indicates a
significantly reduced chance of ROSC and vice versa. Intra-arrest ultrasonographic examination may help
in the decision-making process regarding the termination of cardiopulmonary resuscitation. In addition to
confirming its absence, the presence of LVMA can reinforce enthusiasm of the rescuers to continue
providing high-quality CPR. However, many questions remain unanswered, such as the presence of the
pathophysiological mechanism of LVMA in patients presenting with asystole. It is further unknown
whether myocardial viability depends on the presence of residual cardiac output resulting from LVMA, or
on autonomous blood movement at the level of the microcirculation as observed in our previous study
and documented in several reports (Thompson 1948, Manteuffel-Szoege et al. 1966, Furst 2014). Finally,
it is also necessary to identify whether the phenomenon of LVMA is related only to non-shockable
rhythms, or may also occur in cardiac arrest induced by ventricular fibrillation (VF).
We conducted an experimental study to evaluate the presence of coordinated LVMA in two types of
experimentally induced cardiac arrest: VF and PEA. We hypothesized that LVMA will be detected in the
majority of animals with induced PEA and VF and that its presence will be associated with a longer time
to asystole than in animals without LVMA.
Methods
4
We performed a prospective randomized controlled experimental study on 20 healthy female domestic
experimental pigs (Sus scrofa f. domestica) with weight of 33±2 kg. The experiment was carried out at the
Animal Research Laboratory of the University of Defence, Faculty of Military Health Sciences. The
study protocol was approved by the Animal Investigation Committee of the University of Defence Brno,
Faculty of Military Health Sciences Hradec Kralove, Czech Republic and the Departmental Commission
for the Protection of Animals of the Ministry of Defence, Prague, Czech Republic (approved 14.3.2015,
No. 010-2015). All experimental animals received humane care in compliance with the institutional
guidelines and with the International Association of Veterinary Editors’ Consensus Author Guidelines on
Animal Ethics and Welfare.
Animal preparation
The animals were premedicated by intramuscular injection of azaperone (2.0 mg/kg), atropine (0.2
mg/kg) and ketamine (20.0 mg/kg) 30 minutes before surgery. After the animals were brought into the
operating room, peripheral intravenous access was secured and in a supine position, animals were
intubated and mechanically ventilated 19 breaths/min, FiO2 of 0.4. Tidal volumes were adjusted to
maintain end tidal CO2 of 35-45 mm Hg. Anaesthesia was maintained with a continuous infusion of
fentanyl (5–20 μg/kg/h) and isoflurane inhalation and all animals were given a continuous infusion of
normal saline at room temperature (50 ml/h). Vital signs including ECG were continuously monitored.
The thoracic aorta was cannulated via the carotid artery with a 7F 200 mm catheter Certofix Duo (B.
Braun Melsungen AG, Melsungen, Germany) for monitoring of the aortic blood pressure. An 8.5F
percutaneous sheath introducer (Intro-Flex, Edwards Lifesciences LLC, Irvine, CA, USA) was inserted
via the internal jugular vein into the superior vena cava to facilitate insertion of the bipolar pacing lead
and continual monitoring of right atrial pressure. A 5-mm diameter burr-hole craniotomy at the upper part
of the frontal bone was created on the left side to insert an intracranial pressure-monitoring probe 20 mm
into the frontal lobe (Codman, Johnson & Johnson, Raynham, MA, USA). Coronary perfusion pressure
(CoPP) was calculated as the pressure difference between diastolic aortic pressure and right atrial
5
pressure during the decompression phase. Continuous echocardiographic monitoring was performed by
Vivid i ultrasound device (GE Healthcare, Little Chalfont, United Kingdom).
Left ventricular end-diastolic dimension (LVEDD, mm), left ventricular end-systolic dimension (LVESD,
mm), interventricular septal thickness at end-diastole (IVSd, mm) and posterior wall thickness at end-
diastole (PWd, mm) were recorded every minute and fractional shortening (FS, %) was calculated
following the formula FS = ((LVEDD-LVESD) / LVEDD) · 100. LVMA was defined as the presence of
visible thickening of the interventricular septum and/or left ventricular posterior wall, calculated as FS >0
% and related to opening of the valve.
Experimental protocol
After animal preparation and stabilization, 20 pigs were randomly assigned by envelope method into two
groups to induce either ventricular fibrillation (VF group, 10 animals) or pulseless electrical activity (PEA
group, 10 animals). Ventricular fibrillation (VF) was induced with an alternating current of 510 V using
intra-cardiac bipolar pacing lead introduced into the right ventricle. Pulseless electrical activity (PEA)
was initiated by intravenous administration of T61 agent. Cardiac arrest was confirmed as the time point
at which both the carotid and femoral pulse was no longer palpable. The animals were left in the state of
non-resuscitated cardiac arrest until the cessation of LVMA and sublingual microcirculation. During this
period, the animals were monitored for all variables. Thereafter, the animals were autopsied.
Sublingual microcirculation was recorded in each animal by Sidestream dark-field imaging videocamera
(MicroVision Medical, Amsterdam, Netherlands). All records at baseline were analysed off-line by
specialized software AVA 3.0 (MicroVision Medical, Amsterdam, Netherland) and selected parameters
of the microcirculation were evaluated, namely, perfused vessel density (PVD) and microvascular flow
index (MFI). After initiation of cardiac arrest, the microcirculation was monitored continuously by an
experienced observer. Microcirculatory arrest was defined as cessation of red blood cell movement in the
visual field.
6
Major outcomes were the time from cardiac arrest induction to asystole, the time from cardiac arrest
induction to cessation of LVMA and the time from cardiac arrest induction to cessation of sublingual
microcirculation.
Statistical analysis
For the statistical analysis, measurements were taken at the baseline and each minute until the end of the
experimental protocol. Mean values ± SD or percentages were calculated as necessary. Differences
between groups were compared using the χ2 test, and statistical significance was calculated by the Fischer
exact test for alternative variables. Statistical significance for continuous variables was determined by the
paired Student t test. Data were analysed using Microsoft Excel 2010 (Microsoft, Redmond, WA, USA)
and JMP 3.2 statistical software (SAS Institute, Cary, NC, USA). A p value of <0.05 was considered
statistically significant.
Results
The protocol was completed in all experimental animals. One minute after induction of cardiac arrest,
LVMA was identified in all experimental animals. In the PEA group, it was tightly coupled with the
frequency of QRS complexes on the surface ECG with the heart rate of 106±12/min. In the VF group, we
identified two different patterns of LVMA, regardless of the uniform origin of VF. Six animals exhibited
mechanical contractions of high frequency (subsequently assigned as VFhigh group) and four developed
low frequency contractions (subsequently assigned as VFlow group) (334±12 vs. 125±32/min, p<0.001).
Therefore, we compared three groups in further analysis.
During untreated cardiac arrest, asystole developed in all experimental animals before protocol
termination, first in VFhigh group, followed by PEA and VFlow groups (figure 1). The time to cessation of
LVMA was shortest in VFhigh group, followed by PEA and VFlow groups, respectively (figure 2).
Analysis of the sublingual microcirculation showed normal and comparable values in experimental
groups at the baseline for PVD (24.1±1.1 mm/mm2) and MFI score (2.9±0.1).
7
The time from induction of cardiac arrest to the cessation of microcirculatory flow was shortest in the
group VFhigh, and in comparison, significantly prolonged in the PEA and VFlow groups (figure 3).
Table 1 shows the values of hemodynamic parameters and left ventricular fraction shortening. In the PEA
group, we observed significantly higher maximal values of pulse pressure (PP), CoPP and FS as defined
in the study protocol, and higher values of PP, CoPP and FS in the first three minutes after the induction
of cardiac arrest. Maximal post-arrest values of PP and CoPP were observed in the PEA group
significantly later than in the VFhigh and VFlow groups. There were no significant differences in the DAP
values among the groups during the protocol. However, significant differences in FS during the first three
minutes and at the maximal value were identified between VFhigh and VFlow groups.
Discussion
The main findings of the present study are that LVMA was found to be preserved for a certain period
after induction of CA in all experimental animals regardless of the induced electrical activity, two
patterns of LVMA were identified in VF group animals and the pattern with LVMA of low frequency
contractions (VFlow group) was associated with the longest time from CA induction to asystole to
cessation of LVMA and microcirculation among the groups.
It has been known for some time that the clinical syndrome of cardiac arrest is not always accompanied
by a mechanical cardiac standstill. Bocka et al. performed echocardiography in a group of patients
presenting with electromechanical dissociation and demonstrated synchronous myocardial wall motion in
19 out of 22 patients (Bocka et al. 1988). Paradise et al. measured aortic pressure in 94 patients with PEA
and found that 39 have measurable pulse pressure (6.3 ± 3.5 mm Hg) (Paradis et al. 1992). The
phenomenon of preserved LVMA in patients presenting with PEA is known as pseudo-PEA. Studies have
confirmed that pseudo-PEA is a common finding occurring in 58 % of patients with out-of-hospital, and
in up to 55 % of patients with in-hospital cardiac arrest (Breitkreutz et al. 2010, Flato et al. 2015).
Moreover, LVMA has been identified in up to 35 % cardiac arrest patients with asystole (Breitkreutz et
al. 2010). Blyth et al. performed a meta-analysis of 12 clinical studies and showed that intra-arrest
8
echocardiography had sensitivity of 91.6 % and specificity of 80.0 % as predictors of ROSC. The absence
of LMVA predicts a very low likelihood of ROSC and vice versa (Blyth et al. 2012).
The observed phenomenon of the presence of LVMA in all animals of the PEA group is consistent with
clinical studies published previously (Breitkreutz et al. 2010, Flato et al. 2015).
Surprisingly, we observed the occurrence of LVMA also in animals with induced VF. Unlike in the case
of PEA, there has been no published observations of coordinated LVMA in VF. Moreover, we identified
two patterns of LVMA. In six animals, subsequently assigned to VFhigh group, LVMA was present at the
limit of measurability and at the rate of anticipated frequency of ventricular fibrillation. LVMA at low
frequency was observed in four experimental animals. We now discuss the possible pathophysiological
sequence of events in the VF groups.
In spite of voluminous literature on the causes of electrical myocardial activity during VF, the nature of
its origin, maintenance and hemodynamic impact are not understood. Several experimental and clinical
observations support the hypothesis of an organization pattern” in persistent VF. Wiggers et al.
identified in electrically stimulated canine hearts 4 phases in the genesis of VF. At the onset, a well-
organized type of arrhythmia was observed consisting of one or two rotors with re-entrant electrical
activity, called the mother-rotor. This was followed by less-well organized wavefronts which may
constitute the basis for further rotors (Wiggers et al. 2003). This activity was further defined by Huang et
al. who quantitated the VF and showed that its organization does not invariably decrease, but can
fluctuate (Huang et al. 2004). A controversy continues over the issue whether the dominant cause of VF
is a single re-entrant mother-rotor, or the genesis of newly emerging, wandering wavelets. Experimental
findings shows that, depending on the experimental model, duration and stage of VF and drug therapy,
both mechanisms can be present (Chen et al. 2003, Tabereaux et al. 2009, Fenton et al. 2002, Huang et
al. 1998, Bourgeois et al. 2012, Rogers et al. 2007, Li et al. 2008, Pak et al. 2006, Cheng et al. 2012,
Nielsen et al. 2009, Lin et al. 2014). The heterogeneity in VF maintenance and the complexity of its
electrical activity confirms the importance of visual assessment of LVMA by means of point-of-care
ultrasonography.
9
Another potential mechanism that may explain our observation of different LVMA rate in VFhigh and
VFlow groups is based on the possible role of atrial activity on mechanical left ventricular performance
during VF. In spite of the fact that atrial activity cannot be assessed from the surface ECG during VF,
effective atrial ejection can be present (Addison et al. 2002). In our experiments, VF was induced in
healthy animals with normal sinus rhythm without structural myocardial abnormality. In such
experimental setting, the loss of sinus rhythm after VF induction requires the presence of retrograde
conduction. However, this is not an ubiquitous feature of the conduction system in humans and
experimental animals (Molina et al. 1989, Goldreyer et al. 1970, Bowman et al. 1984, Pickoff et al.
1984). It is possible that the pattern of ongoing, sustained VF presenting with fully organized atrial
activity, i.e., atrial systole, may have been present in some of our experimental animals, giving rise to
pulsatile volume-loading of the left ventricle and directly, or indirectly inducing the echocardiographic
phenomenon of low-frequency LVMA.
It is also possible that in VFlow group the effective atrial activity was preserved and LVMA phenomenon
was predominantly a passive process. In the VFhigh group, on the other hand, the LVMA may reflect high
frequency contractions with minimal FS directly related to VF activity.
It is questionable, however, whether the presence of LVMA characterizes even a minimal degree of
effective cardiac output. What is essential is that various modes of LVMA during VF can be related to
different electrical patterns of VF maintenance and thus to myocardial viability and resistance to
ischemia. We hypothesize that these factors could influence not only defibrillation thresholds but also the
time window for efficient defibrillation.
Is is noteworthy that in the early phase of induced cardiac arrest, LVMA was observed in all experimental
animals. This suggests that LVMA is a regular occurrence in the early phases of
VF and PEA and supports the idea that cardiac arrest is not a static condition but a dynamic process
which, left untreated, inevitable leads to irreversible cardiac standstill.
Finally, we observed flow of blood at the level of the microcirculation well beyond the timing of the
cardiac arrest in all 3 experimental groups (fig 3). The phenomenon of circulation persisting at the organ
and tissue level after the recordable LVMA supports the concept that blood possesses its own kinetic
10
energy determined by the metabolic demands of the tissues and calls for a revision of the conventional,
pressure-propulsion circulation model (Furst 2015, Alexander 2017, Forouhar et al. 2006). Intravital
microscopy of early embryonic circulations has confirmed that a low-pressure circulation already exists
before the functional integrity of the heart (Forouhar et al. 2006). It has further been shown that the
valveless embryo heart functions as an impedance pump which rhythmically interrupts the already
existing flow of blood (Furst 2014). Irrespective of structural differences, the function of the mature heart
is essentially the same as that of the embryonic heart. In addition to rhythmic interruption of the flow, the
ventricles eject the blood into the pulmonary/systemic arterial compartments at higher pressures. Thus,
above the blood’s primary streaming at the level of the microcirculation which is subject to local control,
i.e., organ and tissue autoregulation, the secondary, or macrocirculatory flow is subject to complex
control at the systemic level. According to the ontogenic circulation model the syndrome of cardiac arrest
primarily manifests as the collapse of arterial pressure due to the heart’s inability to rhythmically interrupt
the flow of blood. Even though the resuscitation efforts are primarily directed at restoring a rhythm that
will sustain the macrocirculation, experimental CPR protocols which in addition enhance the
microcirculatory flow have shown favorable outcomes (Yannopoulos et al. 2012). The proposed
circulation model is moreover consistent with recent advances in the understanding of critical illness.
Collectively, they demonstrate uncoupling or incoherence between observed microvascular parameters,
such as functional capillary density and red blood cell velocity, and routinely measured macrovascular
parameters, such as arterial blood pressure, cardiac output, ejection fraction, and mixed venous oxygen
saturation (Ince 2015). The loss of hemodynamic coherence has thus been identified as the common
denominator of various states of shock. Left uncorrected, such incongruence inevitably leads to a
complete dissociation between the two circulatory components and to cardiac arrest. The phenomenon of
persistenting microcirculation after cardiac arrest thus offers a new insight into the pathogenesis and
possible treatment of this insidious condition.
There are a few study limitations. Firstly, this is an experimental study and the results should be
interpreted with caution when related to clinical medicine. Cardiac arrest was induced in healthy young
animals, without any myocardial or pulmonary disease. Since we did not directly measure the intracardiac
11
pressures and ECG’s, only a hypothetical explanation regarding electrical events and intracardiac blood
flows can be given. Secondly, with regard to LVMA patterns, we can not completely rule out effect of
anaesthetics agents on the obtained results in experimental groups. Several authors show that inhaled and
intravenous anaesthetic may have differential, direct or indirect, effect on myocardial functions (Süzer et
al. 1998, De Hert SG 1991, Stowe DF et al. 1992) Addition of fentanyl and sevoflurane was associated
with inhibiting ventricular fibrillation in one clinical report (Yamagishi A et al. 2003). On the other hand,
the same type of anesthesia was used in all experimental animals in comparable doses.
In conclusion, we observed that LVMA was found to be preserved for a certain period of induced cardiac
arrest in all animals in our experiment. In the VF group, two patterns of LVMA were identified, one with
low and one with very high frequency. We hypothesize the underlying mechanism of different LVMA
pattern in animals with induced VF. Anyhow, presentation of LVMA with low frequency contractions was
associated with increased resistance to cessation of LVMA and microcirculation. We also observed the
persistence of microcirculatory blood flow after cardiac standstill. This phenomenon supports the concept
that blood possesses its own kinetic energy determined by the metabolic demands of the tissues and
support a revision of the conventional circulation model. Further research is needed to explain the
pathophysiological explanation of our observations and potential consequences for clinical medicine.
Conflict of interest
We declare no conflict of interest.
Acknowledgments
Supported by the programme PROGRES Q40/2 and by MH CZ - DRO (UHHK, 00179906).
References
ADDISON PS, WATSON JN, CLEGG GR, STEEN PA, ROBERTSON CE: Finding coordinated atrial
activity during ventricular fibrillation using wavelet decomposition. IEEE Eng Med Biol Mag 21: 58-61,
2002.
12
ALEXANDER W: Branko Furst's Radical Alternative: Is the Heart Moved by the Blood, Rather Than
Vice Versa? Pharmacol Ther 42: 33-39, 2017.
BLAIVAS M, FOX JC: Outcome in cardiac arrest patients found to have cardiac standstill on the bedside
emergency department echocardiogram. Acad Emerg Med 8: 616-621, 2001.
BLYTH L, ATKINSON P, GADD K, LANG E: Bedside focused echocardiography as predictor of
survival in cardiac arrest patients: a systematic review. Acad Emerg Med 19: 1119-1126, 2012.
BOCKA JJ, OVERTON DT, HAUSER A: Electromechanical dissociation in human beings: an
echocardiographic evaluation. Ann Emerg Med 17: 450-452, 1988.
BOWMAN TA, HUGHES HC: Ventriculoatrial conduction in swine during cardiac pacing: animal model
for retrograde conduction. Am Heart J 108: 337-341, 1984.
BREITKREUTZ R, PRICE S, STEIGER HV, SEEGER FH, ILPER H, ACKERMANN H, RUDOLPH
M, UDDIN S, WEIGAND MA, MÜLLER E, WALCHER F; Emergency Ultrasound Working Group of
the Johann Wolfgang Goethe-University Hospital, Frankfurt am Main: Focused echocardiographic
evaluation in life support and peri-resuscitation of emergency patients: A prospective trial. Resuscitation
81: 1527-1533, 2010.
BOURGEOIS EB, REEVES HD, WALCOTT GP, ROGERS JM: Panoramic optical mapping shows
wavebreak at a consistent anatomical site at the onset of ventricular fibrillation. Cardiovasc Res 93: 272-
279, 2012.
CHEN PS, WU TJ, TING CT, KARAGUEUZIAN HS, GARFINKEL A, LIN SF, WEISS JN: A Tale of
Two Fibrillations. Circulation 108: 2298-2303, 2003.
CHENG KA, DOSDALL DJ, LI L, ROGERS JM, IDEKER RE, HUANG J: Evolution of activation
patterns during long-duration ventricular fibrillation in pigs. Am J Physiol Heart Circ Physiol 302.
2012;302:H992H1002. doi: 10.1152/ajpheart.00419.2011.
COHN B: Does the absence of cardiac activity on ultrasonography predict failed resuscitation in cardiac
arrest? Ann Emerg Med 62: 180-181, 2013.
13
DE HERT SG: Study on the effects of six intravenous anesthetic agents on regional ventricular function
in dogs (thiopental, etomidate, propofol, fentanyl, sufentanil, alfentanil). Acta Anaesthesiol Belg 42: 3-39,
1991.
FENTON FH, CHERRY EM, HASTINGS HM, EVANS SJ: Multiple mechanisms of spiral wave
breakup in a model of cardiac electrical activity. Chaos 12: 852-892, 2002.
FLATO UAP, PAIVA EF, CARBALLO MT, BUEHLER AM, MARCO R, TIMERMAN A:
Echocardiography for prognostication during the resuscitation of intensive care unit patients with non-
shockable rhythm cardiac arrest. Resuscitation 92: 1-6, 2015.
FOROUHAR AS, LIEBLING M, HICKERSON A, NASIRAEI-MOGHADDAM A, TSAI HJ, HOVE
JR, FRASER SE, DICKINSON ME, GHARIB M: The embryonic vertebrate heart tube is a dynamic
suction pump. Science 312: 751-753, 2006.
FURST B: The Heart: Pressure-Propulsion Pump or Organ of Impedance? J Cardiothorac Vasc Anesth
29: 1688-1701, 2015.
FURST B: The Heart and Circulation - An Integrative Model. London: Springer-Verlag; 2014.
GOLDREYER BBN, BIGGER JT: Ventriculo-atrial Conduction in Man. Circulation 41: 935-946, 1970.
HUANG J, ROGERS JM, KILLINGSWORTH CR, SINGH KP, SMITH WM, IDEKER RE: Evolution
of activation patterns during long-duration ventricular fibrillation in dogs. Am J Physiol Heart Circ
Physiol 286: H1193-H1200, 2004.
HUANG J, ROGERS JM, KENKNIGHT BH, ROLLINS DL, SMITH WM, IDEKER RE: Evolution of
the organization of epicardial activation patterns during ventricular fibrillation. J Cardiovasc
Electrophysiol 9: 1291-1304, 1998.
INCE C: Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care 19
Suppl 3: S8, 2015.
LI L, JIN Q, HUANG J, CHENG K-A, IDEKER RE: Intramural foci during long duration fibrillation in
the pig ventricle. Circ Res 102: 1256-1264, 2008.
14
LIN C, JIN Q, ZHANG N, ZHOU J, PANG Y, XIN Y, LIU S, WU Q, WU L: Endocardial focal
activation originating from Purkinje fibers plays a role in the maintenance of long duration ventricular
fibrillation. Croat Med J 55: 121-127, 2014.
MANTEUFFEL-SZOEGE L, MICHALOWSKI J, GRUNDMAN J, PACOCHA W: On the possibility of
blood circulation continuing after stopping the heart. J Cardiovasc Surg (Torino.) 7: 201-208, 1966.
MOLINA RZ, FUJIMURA O, SHARMA AD, YEE R, KLEIN GJ: Atrioventricular nodal tachycardia in
the absence of retrograde conduction. Can J Cardiol 5: 143-146, 1989.
NIELSEN TD, HUANG J, ROGERS JM, KILLINGSWORTH CR, IDEKER RE: Epicardial mapping of
ventricular fibrillation over the posterior descending artery and left posterior papillary muscle of the
swine heart. J Interv Card Electrophysiol 24: 11-17, 2009.
PAK HN, KIM YH, LIM HE, CHOU CC, MIYAUCHI Y, FANG YH, SUN K, HWANG C, CHEN PS:
Role of the posterior papillary muscle and purkinje potentials in the mechanism of ventricular fibrillation
in open chest dogs and Swine: effects of catheter ablation. J Cardiovasc Electrophysiol 17: 777-783,
2006.
PARADIS NA, MARTIN GB, GOETTING MG, RIVERS EP, FEINGOLD M, NOWAK RM: Aortic
pressure during human cardiac arrest. Identification of pseudo-electromechanical
dissociation. Chest 101: 123-128, 1992.
PICKOFF AS, SINGH S, FLINN CJ, TORRES E, EZRIN AM, GELBAND H: Maturational changes in
ventriculoatrial conduction in the intact canine heart. J Am Coll Cardiol 3: 162-168, 1984.
ROGERS JM, WALCOTT GP, GLADDEN JD, MELNICK SB, KAY MW: Panoramic optical mapping
reveals continuous epicardial reentry during ventricular fibrillation in the isolated swine heart. Biophys J
92: 1090-1095, 2007.
SOAR J, NOLAN JP, BÖTTIGER BW, PERKINS GD, LOTT C, CARLI P, PELLIS T, SANDRONI C,
SKRIFVARS MB, SMITH GB, SUNDE K, DEAKIN CD; Adult advanced life support section
Collaborators: European Resuscitation Council Guidelines for Resuscitation 2015 Section 3. Adult
advanced life support. Resuscitation 95: 100-147, 2015.
15
STOWE DF, BOSNJAK ZJ, KAMPINE JP: Comparison of etomidate, ketamine, midazolam, propofol,
and thiopental on function and metabolism of isolated hearts. Anesth Analg 74: 547-558, 1992.
SÜZER O, SÜZER A, AYKAÇ Z, OZÜNER Z: Direct cardiac effects in isolated perfused rat hearts
measured at increasing concentrations of morphine, alfentanil, fentanyl, ketamine, etomidate,
thiopentone, midazolam and propofol. Eur J Anaesthesiol 15: 480-485, 1998.
TABEREAUX PB, DOSDALL DJ, IDEKER RE: Mechanisms of VF maintenance: wandering wavelets,
mother rotors, or foci. Heart Rhythm 6: 405-415, 2009.
THOMPSON SA: The effect of pulmonary inflation and deflation upon the circulation. J Thorac Surg 17:
323-334, 1948.
WIGGERS CJ, BELL JR, PAINE M: Studies of ventricular fibrillation caused by electric shock: II.
Cinematographic and electrocardiographic observations of the natural process in the dog’s heart. Its
inhibition by potassium and the revival of coordinated beats by calcium. Ann Noninvasive Electrocardiol
8: 252-261, 2003.
YAMAGISHI A, HAMADA I, TAKAHATA O, NAGASHIMA M, FUJIMOTO K, IWASAKI H:
Suppression of frequent ventricular fibrillation attacks after induction of anesthesia with fentanyl,
sevoflurane and propofol: a case report. Masui 52: 750-752, 2003.
YANNOPOULOS D, SEGAL N, MCKNITE S, AUFDERHEIDE TP, LURIE KG: Controlled pauses at
the initiation of sodium nitroprusside-enhanced cardiopulmonary resuscitation facilitate neurological and
cardiac recovery after 15 mins of untreated ventricular fibrillation. Crit Care Med 40: 1562-1569, 2012.
16
Figure 1. Time from induction of cardiac arrest to development of asystole in experimental groups.
Figure 2. Time from induction of cardiac arrest to cessation of LVMA in experimental groups.
LVMA…left ventricular mechanical activity
17
Figure 3. Time from induction of cardiac arrest to cessation of microcirculation.
Table 1. PP, DAP, CoPP and FS values during the protocol and comparison among the groups in different
time points. PP…pulse pressure, DAP…diastolic arterial pressure, CoPP…coronary perfusion pressure,
Tmax…time from cardiac arrest induction to the maximal value during the protocol. * indicates p<0.05
between PEA group and VFhigh and VFlow groups, ● indicates p<0.05 between VFhigh group and VFlow
group
Baseline
1 min
2 min
3. min
Tmax
PP
(mm Hg)
PEA group
45.3±13.5
7.8±2.6*
14.0±8.7*
10.8±6.6*
2.9±0.6*
VFlow group
46.2±12.2
4.3±1.0
4.1±3.1
5.0±5.4
2.2±0.6
VFhigh group
47.0±13.9
4.5±3.1
3.2±1.2
1.5±3.7
1.7±1.0
DAP
(mm Hg)
PEA group
62.3±8.6
19.6±4.5
20.5±6.8
19.6±7.9
2.4±0.8
VFlow group
62.7±13.4
17.3±3.0
16.5±4.0
16.7±3.7
2.0±0.6
VFhigh group
64.2±7.5
17.7±2.9
16.5±0.7
15.7±0.5
2.0±1.4
CoPP
(mm Hg)
PEA group
55.4±8.5
8.6±4.1*
8.2±7.0*
6.9±8.6
2.6±0.8*
VFlow group
56.8±14.8
2.8±1.2
1.3±2.4
2.5±2.9
1.7±0.8
VFhigh group
57.7±5.8
2.7±1.7
2.2±2.7
1.5±2.4
1.5±0.6
FS (%)
PEA group
49.2±6.0
30.9±11.4*
44.1±21.4*
35.3±19.7*
2.1±0.8
VFlow group
51.2±6.2
14.9±8.8
11.4±4.7
9.8±6.4
1.3±0.5
VFhigh group
52.1±1.4
4.4±3.5
5.8±2.4
2.7±0.9
1.7±0,5
... Because the ultimate source for blood propulsion in both models is assumed to be the heart as a pressurepropulsion pump, these opposing views differ only on the surface, not in essence, with little prospect for resolution. A systematic review of the circulation models has shown that neither the conventional 'cardiocentric' nor the alternative venous return circulation model can explain a host of circulatory phenomena (Furst, 2020a). For example, the debate over the source of blood propulsion in the valveless embryo heart (Männer et al., 2010) and in primitive vertebrates without a heart ( Figure 1) continues to be unresolved; mechanical occlusion of the thoracic aorta results in a paradoxical increase, rather than decrease, in CO (Furst, 2020b) and the Fontan procedure, in which a single, weakened ventricle supposedly pumps the blood through the combined resistance of the systemic and pulmonary circulations, presents another, yet-to-be-explained haemodynamic paradox (Furst, 2016(Furst, , 2020c. ...
... High metabolic rates reflected in physiological hyperthermia and hypertension have allowed the birds too overcome gravity and become creatures of air. (Adapted from Furst (2020a), used by permission of Springer-Nature.) An alternative circulation model has recently been proposed in which the peripheral circulation, responding chiefly to metabolic demands of the tissues and organs, plays a primary role in the control of CO (Alexander, 2017;Furst, 2020a). ...
... (Adapted from Furst (2020a), used by permission of Springer-Nature.) An alternative circulation model has recently been proposed in which the peripheral circulation, responding chiefly to metabolic demands of the tissues and organs, plays a primary role in the control of CO (Alexander, 2017;Furst, 2020a). The heart, placed between the pulmonary and systemic circulations, integrates the metabolic, thermoregulatory and respiratory functions and provides a negative feedback control by rhythmically controlling the flow of blood and maintaining or altering perfusion pressure in the pulmonary and systemic circulations (Furst, 2015). ...
Article
Full-text available
Circulation of the blood is a fundamental physiological function traditionally ascribed to the pressure‐generating function of the heart. However, over the past century the ‘cardiocentric’ view has been challenged by August Krogh, Ernst Starling, Arthur Guyton and others, based on haemodynamic data obtained from isolated heart preparations and organ perfusion. Their research brought forth experimental evidence and phenomenological observations supporting the concept that cardiac output occurs primarily in response to the metabolic demands of the tissues. The basic tenets of Guyton's venous return model are presented and juxtaposed with their critiques. Developmental biology of the cardiovascular system shows that the blood circulates before the heart has achieved functional integrity and that its movement is intricately connected with the metabolic demands of the tissues. Long discovered, but as yet overlooked, negative interstitial pressure may play a role in assisting the flow returning to the heart. Based on these phenomena, an alternative circulation model has been proposed in which the heart functions like a hydraulic ram and maintains a dynamic equilibrium between the arterial (centrifugal) and venous (centripetal) forces which define the blood's circular movement. In this focused review we introduce some of the salient arguments in support of the proposed circulation model. Finally, we present evidence that exercising muscle blood flow is subject to local metabolic control which upholds optimal perfusion in the face of a substantive rise in muscle vascular conductance, thus lending further support to the permissive role of the heart in the overall control of blood circulation.
... Continued blood flow without a beating heart raises an obvious question: could the heart be the sole driver of the circulation? Puzzled by clinical and experimental evidence that does not fit the current paradigm, generations of established physicians and physiologists since the 19 th century have repeatedly raised this question [4,[11][12][13][14][15][16][17]. Among those skeptics, the consensus is clear: the heart cannot be the only driver of the circulation; a complementary driving mechanism must exist in blood vessels, presumably in the capillaries [4,[12][13][14][15][16]. ...
... Puzzled by clinical and experimental evidence that does not fit the current paradigm, generations of established physicians and physiologists since the 19 th century have repeatedly raised this question [4,[11][12][13][14][15][16][17]. Among those skeptics, the consensus is clear: the heart cannot be the only driver of the circulation; a complementary driving mechanism must exist in blood vessels, presumably in the capillaries [4,[12][13][14][15][16]. However, the precise mechanism has remained unclear. ...
... However, the precise mechanism has remained unclear. Under the standard pressure-driven flow paradigm, it is not obvious how blood vessels, especially capillaries, could drive blood by themselves [4,[12][13][14][15][16]. eggshell and the eggshell membrane were carefully removed by using a pair of tweezers (Dumont tweezer, Style 55, Domostar, 72707-01) to expose the embryo. ...
Article
Full-text available
The heart is widely acknowledged as the unique driver of blood circulation. Recently, we discovered a flow-driving mechanism that can operate without imposed pressure, using infrared (IR) energy to propel flow. We considered the possibility that, by exploiting this mechanism, blood vessels, themselves, could propel flow. We verified the existence of this driving mechanism by using a three-day-old chick-embryo model. When the heart was stopped, blood continued to flow for approximately 50 minutes, albeit at a lower velocity. When IR was introduced, the postmortem flow increased from ~41.1 ± 25.6 μm/s to ~153.0 ± 59.5 μm/s (n = 6). When IR energy was diminished under otherwise physiological conditions, blood failed to flow. Hence, this IR-dependent, vessel-based flow-driving mechanism may indeed operate in the circulatory system, complementing the action of the heart.
... A common phenomenon described herein is the blunting of peripheral and systemic blood flow, leading to attenuated O 2 delivery to the working muscles, the brain, and other peripheral territories during near-to-maximal aerobic exercise intensities in varied environmental conditions and during prolonged intense exercise with significant dehydration and hyperthermic stress. These temporally linked restrictions in skeletal muscle blood flow and Q give rise to the alternative possibility that regulatory events in the peripheral microcirculation play a crucial role in the output of the heart [44,125,[284][285][286]. Several empirical observations support this hypothesis: (i) artificial pacing of heart rate at rest and during exercise up to maximal aerobic capacity leaves Q and exercising limb blood flow unaltered, suggesting that tachycardia independent of peripheral circulatory events is inconsequential to activity of the heart [125,204,209,[287][288][289]; (ii) incremental exercise in a man with an implanted cardiac pacemaker was associated with substantial elevations in end-diastolic volume, stroke volume, ejection fraction, pulmonary wedge pressure and Q, despite constant heart rate at 100 beats·min −1 , whilst systemic blood flow rose in relation to VO 2 up to 2 L·min −1 [3; page 181]; (iii) increases in conduit artery blood flow during single leg knee-extensor exercise and passive segmental leg heating are accompanied by selective increases in downstream blood flow [246,290]. ...
... An alternative to the cardio-centric model considered in this review is that the regulation of the peripheral circulation, rather than the activity of the heart per se, determines the increase in Q and exercising muscle blood flow during exercise [44,125,[284][285][286]. From a biophysical viewpoint, the heart can be viewed in this unconventional model as an organ of impedance whose mechanical function (comparable to a hydraulic ram) maintains pulmonary and arterial pressure through the cyclic interruption of flow [284,[297][298][299]. Another radical idea supported by the profound increases in leg blood flow and Q during pharmacologically induced vasodilatation (7-8 L·min −1 ) in absence of the muscle pump, changes in metabolism or alterations in perfusion pressure in resting upright seated humans [65], is that the blood possesses autonomous movement [299][300][301]. ...
... An alternative to the cardio-centric model considered in this review is that the regulation of the peripheral circulation, rather than the activity of the heart per se, determines the increase in Q and exercising muscle blood flow during exercise [44,125,[284][285][286]. From a biophysical viewpoint, the heart can be viewed in this unconventional model as an organ of impedance whose mechanical function (comparable to a hydraulic ram) maintains pulmonary and arterial pressure through the cyclic interruption of flow [284,[297][298][299]. Another radical idea supported by the profound increases in leg blood flow and Q during pharmacologically induced vasodilatation (7-8 L·min −1 ) in absence of the muscle pump, changes in metabolism or alterations in perfusion pressure in resting upright seated humans [65], is that the blood possesses autonomous movement [299][300][301]. ...
Article
Full-text available
Claude Bernard’s milieu intérieur (internal environment) and the associated concept of homeostasis are fundamental to the understanding of the physiological responses to exercise and environmental stress. Maintenance of cellular homeostasis is thought to happen during exercise through the precise matching of cellular energetic demand and supply, and the production and clearance of metabolic by-products. The mind-boggling number of molecular and cellular pathways and the host of tissues and organ systems involved in the processes sustaining locomotion, however, necessitate an integrative examination of the body’s physiological systems. This integrative approach can be used to identify whether function and cellular homeostasis are maintained or compromised during exercise. In this review, we discuss the responses of the human brain, the lungs, the heart, and the skeletal muscles to the varying physiological demands of exercise and environmental stress. Multiple alterations in physiological function and differential homeostatic adjustments occur when people undertake strenuous exercise with and without thermal stress. These adjustments can include: hyperthermia; hyperventilation; cardiovascular strain with restrictions in brain, muscle, skin and visceral organs blood flow; greater reliance on muscle glycogen and cellular metabolism; alterations in neural activity; and, in some conditions, compromised muscle metabolism and aerobic capacity. Oxygen supply to the human brain is also blunted during intense exercise, but global cerebral metabolism and central neural drive are preserved or enhanced. In contrast to the strain seen during severe exercise and environmental stress, a steady state is maintained when humans exercise at intensities and in environmental conditions that require a small fraction of the functional capacity. The impact of exercise and environmental stress upon whole-body functions and homeostasis therefore depends on the functional needs and differs across organ systems.
... Based on a systematic research of circulation models, Branko Furst, M.D., professor of anesthesiology, Albany Medical College, Albany, New York, USA, found that this old pressure-propulsion paradigm no longer stands up to the rigor of scientific evidence. [196][197][198][199][200] A comprehensive review of the literature explored in his 2014 monograph (second edition in 2020), The Heart and Circulation: An Integrative Model, 201 and later summarized in a review article, 197 demonstrate that numerous phenomena, ranging from basic cardiovascular physiology to embryology, comparative anatomy and clinical medicine, contradict the conventional pressurepropulsion model. These anomalous findings call for a reappraisal of the mechanistic, solely physicalist view of the cardiovascular system that is so deeply ingrained in the collective scientific, medical, and popular psyche. ...
... In this more holistic model, the diastolic filling, i.e., the flowrestraining function of the heart, is equally as important as the pressure generation and systolic ejection of blood. 197,[201][202][203] Further evidence in support of this anthroposophical view is recent research in embryonic cardiovascular physiology that documents vigorous circulation of blood prior to the development of functional heart values 204 (this and related findings are summarized in Chaps. 1-10 of Furst's monograph). ...
... 1-10 of Furst's monograph). 201 This primary, autonomous blood flow is inextricably linked with tissue metabolic demands and organ/tissue autoregulation. In addition, Furst's monograph points to research of aortic occlusion experiments (Chap. ...
Article
Full-text available
Introduction: Anthroposophic medicine is a form of integrative medicine that originated in Europe but is not well known in the US. It is comprehensive and heterogenous in scope and remains provocative and controversial in many academic circles. Assessment of the nature and potential contribution of anthroposophic medicine to whole person care and global health seems appropriate. Methods: Because of the heterogenous and multifaceted character of anthroposophic medicine, a narrative review format was chosen. A Health Technology Assessment of anthroposophic medicine in 2006 was reviewed and used as a starting point. A Medline search from 2006 to July 2020 was performed using various search terms and restricted to English. Books, articles, reviews and websites were assessed for clinical relevance and interest to the general reader. Abstracts of German language articles were reviewed when available. Reference lists of articles and the author's personal references were also consulted. Results: The literature on anthroposophic medicine is vast, providing new ways of thinking, a holistic view of the world, and many integrating concepts useful in medicine. In the last 20 years there has been a growing research base and implementation of many anthroposophical concepts in the integrated care of patients. Books and articles relevant to describing the foundations, scientific status, safety, effectiveness and criticisms of anthroposophic medicine are discussed. Discussion: An objective and comprehensive analysis of anthroposophic medicine finds it provocative, stimulating and potentially fruitful as an integrative system for whole person care, including under-recognized life processes and psycho-spiritual aspects of human beings. It has a legitimate, new type of scientific status as well as documented safety and effectiveness in some areas of its multimodal approach. Criticisms and controversies of anthroposophic medicine are often a result of lack of familiarity with its methods and approach and/or come from historically fixed ideas of what constitutes legitimate science.
... However, no study to date has explored the associations between heat-related changes in peripheral blood velocity or kinetic energy and the heart's output in humans. Answering this question will not only shed light on the longstanding debate of what drives blood circulation (Folkow & Neil, 1971;Furst, 2020;Furst & González-Alonso, 2024;Guyton, 1967;Joyce & Wang, 2021;Krogh, 1912a,b;Patterson & Starling, 1914;Rowell, 1993), but will also help establish the effectiveness of passive lower-limb heating as a therapeutic intervention to improve cardiovascular health. ...
... The classic cardiocentric postulate is that the heart is the primary organ generating the mechanical energy (pressure energy) to distribute systemic blood flow to organs and tissues (Rowell, 1993;Secomb, 2016). This view has been termed the pressure-propulsion model (Furst, 2020;Furst & González-Alonso, 2024), and is exemplified by the close temporal relationship between the blood pressure and flow waves in the aorta (Khir & Parker, 2005;Mynard et al., 2018;Parker & Jones, 1990) and the conduit arteries (Nichols et al., 2022). The observation that arterial, central venous and femoral venous pressures are maintained or only slightly altered (e.g. ...
Article
Full-text available
Passive whole‐body hyperthermia increases limb blood flow and cardiac output (Q̇Q˙\dot Q), but the interplay between peripheral and central thermo‐haemodynamic mechanisms remains unclear. Here we tested the hypothesis that local hyperthermia‐induced alterations in peripheral blood flow and blood kinetic energy modulate flow to the heart and Q̇Q˙\dot Q. Body temperatures, regional (leg, arm, head) and systemic haemodynamics, and left ventricular (LV) volumes and functions were assessed in eight healthy males during: (1) 3 h control (normothermic condition); (2) 3 h of single‐leg heating; (3) 3 h of two‐leg heating; and (4) 2.5 h of whole‐body heating. Leg, forearm, and extracranial blood flow increased in close association with local rises in temperature while brain perfusion remained unchanged. Increases in blood velocity with small to no changes in the conduit artery diameter underpinned the augmented limb and extracranial perfusion. In all heating conditions, Q̇Q˙\dot Q increased in association with proportional elevations in systemic vascular conductance, related to enhanced blood flow, blood velocity, vascular conductance and kinetic energy in the limbs and head (all R² ≥ 0.803; P < 0.001), but not in the brain. LV systolic (end‐systolic elastance and twist) and diastolic functional profiles (untwisting rate), pulmonary ventilation and systemic aerobic metabolism were only altered in whole‐body heating. These findings substantiate the idea that local hyperthermia‐induced selective alterations in peripheral blood flow modulate the magnitude of flow to the heart and Q̇Q˙\dot Q through changes in blood velocity and kinetic energy. Localised heat‐activated events in the peripheral circulation therefore affect the human heart's output. image Key points Local and whole‐body hyperthermia increases limb and systemic perfusion, but the underlying peripheral and central heat‐sensitive mechanisms are not fully established. Here we investigated the regional (leg, arm and head) and systemic haemodynamics (cardiac output: Q̇Q˙\dot Q) during passive single‐leg, two‐leg and whole‐body hyperthermia to determine the contribution of peripheral and central thermosensitive factors in the control of human circulation. Single‐leg, two‐leg, and whole‐body hyperthermia induced graded increases in leg blood flow and Q̇Q˙\dot Q. Brain blood flow, however, remained unchanged in all conditions. Ventilation, extracranial blood flow and cardiac systolic and diastolic functions only increased during whole‐body hyperthermia. The augmented Q̇Q˙\dot Q with hyperthermia was tightly related to increased limb and head blood velocity, flow and kinetic energy. The findings indicate that local thermosensitive mechanisms modulate regional blood velocity, flow and kinetic energy, thereby controlling the magnitude of flow to the heart and thus the coupling of peripheral and central circulation during hyperthermia.
... Its rhythmic contractions propel blood throughout the body, delivering oxygen and nutrients to various tissues and organs, while simultaneously transporting metabolic waste to the lungs and kidneys for excretion. [26] This process ensures the proper functioning of physiological systems and maintains the homeostatic balance of the internal environment. The heart is structurally composed of two atria and two ventricles, with each chamber having a distinct role. ...
Article
Full-text available
Heart disease remains a leading cause of mortality worldwide, posing a significant challenge to global healthcare systems. Traditional animal models and cell culture techniques are instrumental in advancing the understanding of cardiac pathophysiology. However, these methods are limited in their ability to fully replicate the heart's intricate functions. This underscores the need for a deeper investigation into the fundamental mechanisms of heart disease. Notably, cardiac pathology is often influenced by systemic factors, with conditions in other organs contributing to disease onset and progression. Cardiac‐focused multi‐organ chip technology has emerged to better elucidate these complex inter‐organ communications and address the limitations of current in vitro models. This technology offers a novel approach by recreating the cardiac microenvironment and integrating it with other organ systems, thereby enabling more precise disease modeling and drug toxicity assessment. This review provides a comprehensive overview of the heart's structure and function, explores the advancements in cardiac organ chip development, and highlights the applications of cardiac‐focused multi‐organ chips in medical research. Finally, the future potential of this technology in enhancing disease modeling and therapeutic evaluation is discussed.
... Atherosclerosis is the most common form of arteriosclerosis (hardening of the arteries) and, through its contribution to heart disease and stroke, is responsible for about 31% of deaths in the United States, Europe, and Japan (Furst, 2019;Kassab, 2019). In atherosclerosis, localized plaques, or atheromas, protrude into the lumen of the artery and thus reduce blood flow. ...
Article
Hemodynamic factors play a role in atherogenesis and the localization of atherosclerotic plaques. The human aorta and coronary arteries are susceptible to arterial disease, and there have been many studies of flows in models of these vessels. Atherosclerosis is a systemic disease occurring in specific sections of the cardiovascular tree such as the carotid and the coronary arteries. This paper aims to simulate the human arterial bifurcation and investigates some hemodynamic parameters as blood propagates from the aortic artery toward the carotid artery. We analyze the velocity, static pressure, shear stress. The simulation results showed disturbed flow patterns, such as flow separation and stagnation, as well as abnormal hemodynamic parameters (HPs) distributions including the low and high wall shear stress (WSS) and oscillation of wall shear stress. Based on our simulating characteristic results, the CFD tools can not only monitor the hemodynamic parameters obviously, but also help to analyze the diagnostic for the treatment of vascular diseases. CFD can be an effective technology for the examination and treatment of patients with failure of blood supply of the head and brain.
Article
Full-text available
Nanogenerators are a recently emerging technology which is able to cost-effectively harvest energy from renewable and clean energy sources at the micro/nano-scale. Their applications in the field of self-powered sensing systems and portable power supplying devices have been increasing in recent years. Wearable and implantable electromechanical/electrochemical transducers for energy harvesting represent a novel alternative to chemical batteries for low-power devices and to exploit the energy conveyed by human biomechanics. The human heart, in particular, is a compelling in vivo source of continuous biomechanical energy and is a natural battery which can power implantable or wearable medical devices. This review describes the recent advances in cardiac wearable/implantable soft and flexible devices and nanogenerators for energy harvesting (piezoelectric nanogenerators, triboelectric nanogenerators, biofuel cells, solar cells, etc.), as well as cardiovascular implantable electronic devices in a more general sense, as components of more complex self-sustainable bioelectronic systems for controlling irregular heartbeats or for interventional therapy for cardiac diseases. The main types of soft heart energy harvesters (HEHs) and heart bioelectronic systems (HBSs) are covered and classified, with a detailed presentation of state-of-the-art devices, and the advances in terms of materials choice, chemical functionalization, and design engineering are highlighted. In vivo bioelectronic cardiac interfaces are outlined as well as soft devices for in vitro cardiac models (patch and organoids). Cutting-edge 3D/4D bioprinting techniques of cardiac tissue are also mentioned. The technical challenges for the practical application and commercialization of soft HBSs are discussed at the end of this paper.
Preprint
Full-text available
The heart is widely acknowledged as the unique driver of blood circulation. Recently, we discovered a flow-driving mechanism that can operate without imposed pressure, using infrared (IR) energy to propel flow. We considered the possibility that, by exploiting this mechanism, blood vessels, themselves, could propel flow. We verified the existence of this driving mechanism by using a three-day-old chick-embryo model. When the heart was stopped, blood continued to flow, albeit at a lower velocity. When IR was introduced, flow increased, by ~300%. When IR energy was diminished under otherwise physiological conditions, blood failed to flow. Hence, this IR-dependent, vessel-based flow-driving mechanism may indeed operate in the circulatory system, complementing the action of the heart.
Article
Full-text available
This article presents a personal viewpoint of the shortcoming of conventional hemodynamic resuscitation procedures in achieving organ perfusion and tissue oxygenation following conditions of shock and cardiovascular compromise, and why it is important to monitor the microcirculation in such conditions. The article emphasizes that if resuscitation procedures are based on the correction of systemic variables, there must be coherence between the macrocirculation and microcirculation if systemic hemodynamic-driven resuscitation procedures are to be effective in correcting organ perfusion and oxygenation. However, in conditions of inflammation and infection, which often accompany states of shock, vascular regulation and compensatory mechanisms needed to sustain hemodynamic coherence are lost, and the regional circulation and microcirculation remain in shock. We identify four types of microcirculatory alterations underlying the loss of hemodynamic coherence: type 1, heterogeneous microcirculatory flow; type 2, reduced capillary density induced by hemodilution and anemia; type 3, microcirculatory flow reduction caused by vasoconstriction or tamponade; and type 4, tissue edema. These microcirculatory alterations can be observed at the bedside using direct visualization of the sublingual microcirculation with hand-held vital microscopes. Each of these alterations results in oxygen delivery limitation to the tissue cells despite the presence of normalized systemic hemodynamic variables. Based on these concepts, we propose how to optimize the volume of fluid to maximize the oxygen-carrying capacity of the microcirculation to transport oxygen to the tissues.
Article
Full-text available
Article
Full-text available
Aim To determine the role of repetitive endocardial focal activations and Purkinje fibers in the maintenance of long duration ventricular fibrillation (LDVF, VF>1 minute) in canine hearts in vivo. Methods The study was conducted in electrophysiological laboratory of Shanghai Ruijin hospital from July 2010 to August 2012. A 64-electrode basket was introduced through a carotid artery into the left ventricle (LV) of 11 beagle dogs for global endocardial electrical mapping. In the Lugol’s solution group (n = 5), the subendocardium was ablated by washing with Lugol’s solution. In the control group, (n = 6) saline was used for ablation. Before and after saline or Lugol ablation, we determined QRS duration and QT/QTc interval in sinus rhythm (SR). We also measured the activation rates in the first 2 seconds of each minute during 7 minutes of VF for each group. If VF terminated spontaneously in less than 7 minutes, the VF segments used in activation rate analysis were reduced accordingly. Results At the beginning of VF there was no difference between the groups in the activation rate. However, after 1 minute of LDVF the Lugol’s solution group had significantly slower activation rate than the control group. In the control group, all episodes of LDVF (6/6) were successfully sustained for 7 minutes, while in the Lugol’s solution group 4/5 episodes of LDVF spontaneously terminated before 7 minutes (4.8 ± 1.4 minutes) (P = 0.015). In the control group, at 5.1 ± 1.3 minutes of LDVF, a successive, highly organized focal LV endocardial activation pattern was observed. During this period, activations partly arose in PF and spread to the working ventricular myocardium. Mapping analysis showed that these events were consistent with repetitive endocardial focal activations. No evidence of similar focal activations was observed in the Lugol’s solution group. Conclusions Repetitive endocardial focal activations in the LV endocardium may be associated with activation of subendocardial PFs. This mechanism may play an important role in the maintenance of LDVF.
Article
The authors examined direct myocardial and coronary vascular responses to the anesthetic induction agents etomidate, ketamine, midazolam, propofol, and thiopental and compared their effects on attenuating autoregulation of coronary flow as assessed by changes in oxygen supply/demand relationships. Spontaneous heart rate, atrioventricular conduction time during atrial pacing, left ventricular pressure (LVP), coronary flow (CF), percent oxygen extraction, oxygen delivery, and myocardial oxygen consumption (MVO2) were examined in 55 isolated guinea pig hearts divided into five groups of 11 each. Hearts were perfused at constant pressure with one of the drugs administered at steady-state concentrations increasing from 0.5-mu-M to 1 mM. Adenosine was given to test maximal CF. At concentrations below 10-mu-M no significant changes were observed; beyond 50-mu-M for midazolam, etomidate, and propofol, and 100-mu-M for thiopental and ketamine, each agent caused progressive but differential decreases in heart rate, atrioventricular conduction time (leading to atrioventricular dissociation), LVP, +dLVP/dt(max), percent oxygen extraction, and MVO2. The concentrations (mu-M) at which +dLVP/dt(max) was reduced by 50% were as follows: etomidate, 82 +/- 2 (mean +/- SEM); propofol, 91 +/- 4; midazolam, 105 +/- 8; thiopental, 156 +/- 11; and ketamine, 323 +/- 7; the rank order of potency was etomidate = propofol = midazolam > thiopental > ketamine; results were similar for LVP. At the 100-mu-M concentration, CF was decreased 11% +/- 2% by ketamine and 5% +/- 3% by thiopental but was increased 17% +/- 6% by etomidate, 21% +/- 5% by midazolam, and near maximally to 57% +/- 10% by propofol; MVO2 was decreased 8% +/- 4% by thiopental, 10% +/- 5% by ketamine, 19% +/- 5% by midazolam, 29% +/- 7% by etomidate, and 37% +/- 5% by propofol; oxygen delivery/MVO2 was unchanged by thiopental and ketamine but was increased 62% +/- 7% by midazolam, 71% +/- 9% by etomidate, and 150% +/- 15% by propofol. Between 100-mu-M and 1 mM, thiopental and ketamine did not increase CF but decreased MVO2 and percent oxygen extraction, whereas propofol maximally increased CF and decreased MVO2 and midazolam and etomidate had intermediate effects. These results indicate that on a molar basis, propofol, and less so midazolam and etomidate, depress cardiac function moderately more than thiopental and ketamine, and that propofol markedly attenuates autoregulation by causing coronary vasodilation. With doses used to induce anesthesia, propofol and thiopental appear to depress cardiac function more than ketamine or etomidate.
Article
Transthoracic echocardiography (TTE) during cardiopulmonary arrest (CPA) has been studied in victims of cardiac arrests. Our objective was to evaluate the feasibility and usefulness of TTE in victims of cardiac arrest with non-shockable rhythms hospitalized in intensive care units (ICUs). This prospective and observational cohort study evaluated ICU patients with CPA in asystole or pulseless electrical activity (PEA). Intensivists performed TTE during intervals of up to 10seconds as established in the treatment protocol. Myocardial contractility was defined as intrinsic movement of the myocardium coordinated with cardiac valve movement. PEA without contractility was classified as electromechanical dissociation (EMD), and with contractility as pseudo-EMD. The images, the rates of return of spontaneous circulation (ROSC) and the survival upon hospital discharge and after 180 days were evaluated. A total of 49 patients were included. Image quality was considered adequate in all cases and contributed to the diagnosis of CPA in 51.0% of the patients. Of the 49 patients included, 17 (34.7%) were in asystole and 32 (65.3%) in PEA, among which 5 (10.2%) were in EMD and 27 (55.1%) in pseudo-EMD. The rates of ROSC were 70.4% for those in pseudo-EMD, 20.0% for those in EMD, and 23.5% for those in asystole. Survival upon hospital discharge and after 180 days occurred only in patients in pseudo-EMD (22.2% and 14.8%, respectively). TTE conducted during cardiopulmonary resuscitation in ICU patients can be performed without interfering with care protocols and can contribute to the differential diagnosis of CPA and to the identification of a subgroup of patients with better prognosis. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Article
Patients presenting in cardiac arrest frequently have poor outcomes despite heroic resuscitative measures in the field. Many emergency medical systems have protocols in place to stop resuscitative measures in the field; however, further predictors need to be developed for cardiac arrest patients brought to the emergency department (ED). To examine the predictive value of cardiac standstill visualized on bedside ED echocardiograms during the initial presentations of patients receiving cardiopulmonary resuscitation (CPR). The study took place in a large urban community hospital with an emergency medicine residency program and a high volume of cardiac arrest patients. As part of routine care, all patients arriving with CPR in progress were subject to immediate and brief subxiphoid or parasternal cardiac ultrasound examination. This was followed by brief repeat ultrasound examination during the resuscitation when pulses were checked. A 2.5-MHz phased-array probe was used for imaging. Investigators filled out standardized data sheets. Examinations were taped for review. Statistical analysis included descriptive statistics, positive and negative predictive values, and likelihood ratios. One hundred sixty-nine patients were enrolled in the study. One hundred thirty-six patients had cardiac standstill on the initial echocardiogram. Of these, 71 patients had an identifiable rhythm on monitor. No patient with sonographically identified cardiac standstill survived to leave the ED regardless of his or her initial electrical rhythm. Cardiac standstill on echocardiogram resulted in a positive predictive value of 100% for death in the ED, with a negative predictive value of 58%. Patients presenting with cardiac standstill on bedside echocardiogram do not survive to leave the ED regardless of their electrical rhythms. This finding was uniform regardless of downtime. Although larger studies are needed, this may be an additional marker for cessation of resuscitative efforts.
Article
A multipronged approach to improve vital organ perfusion during cardiopulmonary resuscitation that includes sodium nitroprusside, active compression-decompression cardiopulmonary resuscitation, an impedance threshold device, and abdominal pressure (sodium nitroprusside-enhanced cardiopulmonary resuscitation) has been recently shown to increase coronary and cerebral perfusion pressures and higher rates of return of spontaneous circulation vs. standard cardiopulmonary resuscitation. To further reduce reperfusion injury during sodium nitroprusside-enhanced cardiopulmonary resuscitation, we investigated the addition of adenosine and four 20-sec controlled pauses spread throughout the first 3 mins of sodium nitroprusside-enhanced cardiopulmonary resuscitation. The primary study end point was 24-hr survival with favorable neurologic function after 15 mins of untreated ventricular fibrillation. Randomized, prospective, blinded animal investigation. Preclinical animal laboratory. Thirty-two female pigs (four groups of eight) 32±2 kg. After 15 mins of untreated ventricular fibrillation, isoflurane-anesthetized pigs received 5 mins of either standard cardiopulmonary resuscitation, sodium nitroprusside-enhanced cardiopulmonary resuscitation, sodium nitroprusside-enhanced cardiopulmonary resuscitation+adenosine, or controlled pauses-sodium nitroprusside-enhanced cardiopulmonary resuscitation+adenosine. After 4 mins of cardiopulmonary resuscitation, all animals received epinephrine (0.5 mg) and a defibrillation shock 1 min later. Sodium nitroprusside-enhanced cardiopulmonary resuscitation-treated animals received sodium nitroprusside (2 mg) after 1 min of cardiopulmonary resuscitation and 1 mg after 3 mins of cardiopulmonary resuscitation. After 1 min of sodium nitroprusside-enhanced cardiopulmonary resuscitation, adenosine (24 mg) was administered in two groups. A veterinarian blinded to the treatment assigned a cerebral performance category score of 1-5 (normal, slightly disabled, severely disabled but conscious, vegetative state, or dead, respectively) 24 hrs after return of spontaneous circulation. Sodium nitroprusside-enhanced cardiopulmonary resuscitation, sodium nitroprusside-enhanced cardiopulmonary resuscitation+adenosine, and controlled pauses-sodium nitroprusside-enhanced cardiopulmonary resuscitation+adenosine resulted in a significantly higher 24-hr survival rate compared to standard cardiopulmonary resuscitation (7 of 8, 8 of 8, and 8 of 8 vs. 2 of 8, respectively p<.05). The mean cerebral performance category scores for standard cardiopulmonary resuscitation, sodium nitroprusside-enhanced cardiopulmonary resuscitation, sodium nitroprusside-enhanced cardiopulmonary resuscitation+adenosine, or controlled pauses-sodium nitroprusside-enhanced cardiopulmonary resuscitation+adenosine were 4.6±0.7, 3±1.3, 2.5±0.9, and 1.5±0.9, respectively (p<.01 for controlled pauses-sodium nitroprusside-enhanced cardiopulmonary resuscitation+adenosine compared to all other groups). Reducing reperfusion injury and maximizing circulation during cardiopulmonary resuscitation significantly improved functional neurologic recovery after 15 mins of untreated ventricular fibrillation. These results suggest that brain resuscitation after prolonged cardiac arrest is possible with novel, noninvasive approaches focused on reversing the mechanisms of tissue injury.